A Pragmatic Randomized Feasibility Trial of Influenza Vaccines
Authors:
- 24 January 2023
- journal article
- research article
- Published by Massachusetts Medical Society in NEJM Evidence
- Vol. 2 (2)
Abstract
Randomized Feasibility Trial of Influenza VaccinesThis pragmatic, open-label, active-controlled, randomized feasibility trial of QIV-HD versus QIV-SD was conducted in Danish citizens aged 65 to 79 years during the 2021-2022 influenza season. Randomization was integrated into routine vaccination practice. Only nationwide administrative health registries were used for data collection.Keywords
This publication has 33 references indexed in Scilit:
- External validity of a randomised controlled trial on the treatment of severe infections caused by MRSABMJ Open, 2015
- Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccinesVaccine, 2015
- Registry-based randomized clinical trials—a new clinical trial paradigmNature Reviews Cardiology, 2015
- Influenza Vaccine Effectiveness in the 2011–2012 Season: Protection Against Each Circulating Virus and the Effect of Prior Vaccination on EstimatesClinical Infectious Diseases, 2013
- Randomized Clinical Trials — Removing Unnecessary ObstaclesNew England Journal of Medicine, 2013
- Early Patterns of Gene Expression Correlate With the Humoral Immune Response to Influenza Vaccination in HumansThe Journal of Infectious Diseases, 2011
- Accuracy of a Heart Failure Diagnosis in Administrative RegistersEuropean Journal of Heart Failure, 2008
- Do we need to adjudicate major clinical events?Clinical Trials, 2008
- External Validity of Clinical Trials in Acute Myocardial InfarctionArchives of internal medicine (1960), 2007
- The Efficacy of Influenza Vaccine in Elderly PersonsAnnals of Internal Medicine, 1995